🇺🇸 FDA
Patent

US 9833498

Methods of treatment of collagen-mediated diseases and conditions

granted A61KA61K38/4813A61K38/482

Quick answer

US patent 9833498 (Methods of treatment of collagen-mediated diseases and conditions) held by HALOZYME, INC. expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
HALOZYME, INC.
Grant date
Tue Dec 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K38/4813, A61K38/482, A61K38/4873, A61K38/488